Literature DB >> 20610356

Chronic kidney disease and end-stage renal disease in the elderly population: current prevalence, future projections, and clinical significance.

Lesley A Stevens1, Gautham Viswanathan, Daniel E Weiner.   

Abstract

The world's population is aging, with the number of older adults projected to increase dramatically over the next 2 decades. This trend poses major challenges to health care systems, reflecting the greater health care use and more comorbid conditions among elderly adults. Chronic kidney disease (CKD) is a substantial concern in the elderly population, with both an increasing incidence of treated kidney failure with dialysis as well as a high prevalence of earlier stages of CKD. Given the high burden of risk factors for CKD, the high prevalence of CKD in the elderly population is not surprising, with the rise in obesity, diabetes, and hypertension in middle-aged adults likely foreshadowing further increases in CKD prevalence among the elderly population. It is now commonly agreed that the presence of CKD identifies a higher risk state in the elderly population, with increased risk for multiple adverse outcomes, including kidney failure, cardiovascular disease, cognitive impairment, and death. Accordingly, CKD in older adults is worthy of attention by both health care providers and patients, with the presence of a reduced glomerular filtration rate or albuminuria in the elderly potentially informing therapeutic and diagnostic decisions for these individuals. 2010 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20610356      PMCID: PMC3160131          DOI: 10.1053/j.ackd.2010.03.010

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN: 1548-5595            Impact factor:   3.620


  57 in total

1.  Doc, don't procrastinate...Rehabilitate, palliate, and advocate.

Authors:  S Vanita Jassal; Diane Watson
Journal:  Am J Kidney Dis       Date:  2010-02       Impact factor: 8.860

2.  Trends in patient characteristics and first-year medical costs of older incident hemodialysis patients, 1995-2005.

Authors:  Lih-Wen Mau; Jiannong Liu; Yang Qiu; Haifeng Guo; Areef Ishani; Thomas J Arneson; David T Gilbertson; Stephan C Dunning; Allan J Collins
Journal:  Am J Kidney Dis       Date:  2010-02-08       Impact factor: 8.860

3.  Podocyte number predicts long-term urinary albumin excretion in Pima Indians with Type II diabetes and microalbuminuria.

Authors:  T W Meyer; P H Bennett; R G Nelson
Journal:  Diabetologia       Date:  1999-11       Impact factor: 10.122

4.  Prevalence of multiple chronic conditions in the United States' Medicare population.

Authors:  Kathleen M Schneider; Brian E O'Donnell; Debbie Dean
Journal:  Health Qual Life Outcomes       Date:  2009-09-08       Impact factor: 3.186

5.  Outcomes of hemodialysis patients in a long-term care hospital setting: a single-center study.

Authors:  Charuhas V Thakar; Margaret Quate-Operacz; Anthony C Leonard; Mark H Eckman
Journal:  Am J Kidney Dis       Date:  2009-12-16       Impact factor: 8.860

6.  Prevalence and trends in obesity among US adults, 1999-2008.

Authors:  Katherine M Flegal; Margaret D Carroll; Cynthia L Ogden; Lester R Curtin
Journal:  JAMA       Date:  2010-01-13       Impact factor: 56.272

7.  The burden of amputation among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Authors:  Christian Combe; Justin M Albert; Jennifer L Bragg-Gresham; Vittorio E Andreucci; Alex Disney; Shunichi Fukuhara; David A Goodkin; Brenda W Gillespie; Akira Saito; Michel Jadoul; Ronald L Pisoni
Journal:  Am J Kidney Dis       Date:  2009-07-19       Impact factor: 8.860

8.  Functional status of elderly adults before and after initiation of dialysis.

Authors:  Manjula Kurella Tamura; Kenneth E Covinsky; Glenn M Chertow; Kristine Yaffe; C Seth Landefeld; Charles E McCulloch
Journal:  N Engl J Med       Date:  2009-10-15       Impact factor: 91.245

9.  Rate of kidney function decline in older adults: a comparison using creatinine and cystatin C.

Authors:  Michael G Shlipak; Ronit Katz; Bryan Kestenbaum; Linda F Fried; Anne B Newman; David S Siscovick; Lesley Stevens; Mark J Sarnak
Journal:  Am J Nephrol       Date:  2009-04-07       Impact factor: 3.754

10.  The frequency of hyperkalemia and its significance in chronic kidney disease.

Authors:  Lisa M Einhorn; Min Zhan; Van Doren Hsu; Lori D Walker; Maureen F Moen; Stephen L Seliger; Matthew R Weir; Jeffrey C Fink
Journal:  Arch Intern Med       Date:  2009-06-22
View more
  80 in total

1.  Lithium Treatment for Agitation in Alzheimer's disease (Lit-AD): Clinical rationale and study design.

Authors:  D P Devanand; Jesse G Strickler; Edward D Huey; Elizabeth Crocco; Brent P Forester; Mustafa M Husain; Ipsit V Vahia; Howard Andrews; Melanie M Wall; Gregory H Pelton
Journal:  Contemp Clin Trials       Date:  2018-05-31       Impact factor: 2.226

Review 2.  MRI-detectable nanoparticles: the potential role in the diagnosis of and therapy for chronic kidney disease.

Authors:  Jennifer R Charlton; Scott C Beeman; Kevin M Bennett
Journal:  Adv Chronic Kidney Dis       Date:  2013-11       Impact factor: 3.620

3.  Baseline chronic kidney disease does not predict long-term renal functional decline after percutaneous nephrolithotomy.

Authors:  Kara L Watts; Abhishek Srivastava; Wilson Lin; Daniel Schoenfeld; Matthew Abramowitz; Joshua M Stern
Journal:  Urolithiasis       Date:  2019-02-12       Impact factor: 3.436

4.  Potentially inappropriate prescribing of renally cleared drugs in elderly patients in community and aged care settings.

Authors:  Aarati Khanal; Gregory M Peterson; Ronald L Castelino; Matthew D Jose
Journal:  Drugs Aging       Date:  2015-05       Impact factor: 3.923

Review 5.  The assessment of cognitive function in older adult patients with chronic kidney disease: an integrative review.

Authors:  Mary Hannan; Alana Steffen; Lauretta Quinn; Eileen G Collins; Shane A Phillips; Ulf G Bronas
Journal:  J Nephrol       Date:  2018-05-25       Impact factor: 3.902

6.  The kidney disease quality of life cognitive function subscale and cognitive performance in maintenance hemodialysis patients.

Authors:  Eric P Sorensen; Mark J Sarnak; Hocine Tighiouart; Tammy Scott; Lena M Giang; Bethany Kirkpatrick; Kristina Lou; Daniel E Weiner
Journal:  Am J Kidney Dis       Date:  2012-03-15       Impact factor: 8.860

7.  Multiple medication (polypharmacy) and chronic kidney disease in patients aged 60 and older: a pharmacoepidemiologic perspective.

Authors:  Ankit Sutaria; Longjian Liu; Ziauddin Ahmed
Journal:  Ther Adv Cardiovasc Dis       Date:  2016-02-25

8.  Uremia induces upregulation of cerebral tissue oxidative/inflammatory cascade, down-regulation of Nrf2 pathway and disruption of blood brain barrier.

Authors:  Wanghui Jing; Bahman Jabbari; Nosratola D Vaziri
Journal:  Am J Transl Res       Date:  2018-07-15       Impact factor: 4.060

9.  Clinical outcomes in elderly patients on chronic peritoneal dialysis: a retrospective study from a single center in china.

Authors:  Upendra Joshi; Qunying Guo; Chunyan Yi; Rong Huang; Zhijian Li; Xueqing Yu; Xiao Yang
Journal:  Perit Dial Int       Date:  2013-12-01       Impact factor: 1.756

10.  Diagnostic value of screening instruments for identifying obstructive sleep apnea in kidney failure.

Authors:  David D M Nicholl; Sofia B Ahmed; Andrea H S Loewen; Brenda R Hemmelgarn; Darlene Y Sola; Jaime M Beecroft; Tanvir C Turin; Patrick J Hanly
Journal:  J Clin Sleep Med       Date:  2013-01-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.